Search results
Katalin "Kati" Karikó (Hungarian: Karikó Katalin, pronounced [ˈkɒrikoː ˌkɒtɒlin]; born 17 January 1955) is a Hungarian-American biochemist who specializes in ribonucleic acid -mediated mechanisms, particularly in vitro-transcribed messenger RNA (mRNA) for protein replacement therapy.
Katalin Karikó. BioNTech RNA Pharmaceuticals. Verified email at upenn.edu. mRNA-based therapy for protein replacement.
Katalin KARIKÓ, Adjunct professor | Cited by 19,254 | of University of Pennsylvania, PA (UP) | Read 157 publications | Contact Katalin KARIKÓ
Oct 2, 2023 · The Nobel Prize in Physiology or Medicine 2023 was awarded jointly to Katalin Karikó and Drew Weissman "for their discoveries concerning nucleoside base modifications that enabled the development of effective mRNA vaccines against COVID-19"
Katalin Karikó. The Nobel Prize in Physiology or Medicine 2023. Born: 17 January 1955, Szolnok, Hungary. Affiliation at the time of the award: Szeged University, Szeged, Hungary; University of Pennsylvania, Philadelphia, PA, USA.
Oct 2, 2023 · This year’s Nobel Prize in Physiology or Medicine has been awarded to biochemist Katalin Karikó and immunologist Drew Weissman for discoveries that enabled the development of mRNA vaccines ...
Katalin Karikó, PhD, is a biochemist and researcher, best known for her contributions to mRNA technology and the COVID-19 vaccines. Karikó and Drew Weissman, MD, PhD, were jointly awarded the 2023 Nobel Prize in Medicine for their discoveries that enabled the modified mRNA technology used in Pfizer-BioNTech and Moderna’s vaccines to prevent ...
Apr 29, 2022 · The woman behind this ground-breaking technology is Dr. Katalin Karikó, currently working at BioNTech RNA Pharmaceuticals Company (Germany) and Perelman School of Medicine at the University of Pennsylvania, USA. Dr. Karikó’s path to her current success is a journey of passion and happiness as well as hardships, especially as a female scientist.
Oct 1, 2021 · Dr. Katalin Karikó’s research has for decades focused on RNA-mediated mechanisms, with the ultimate goal of developing in vitro-transcribed mRNA for protein therapy.
Her ground-breaking work on RNA led to an entirely new type of vaccine, yet Katalin Karikó spent most of her career in obscurity, searching for funding to support her research.
